1. Independent Validation of the Modified Prognosis Palliative Care Study Predictor Models in Three Palliative Care Settings 
Mika Baba, MD, Isseki Maeda, MD, PhD, Tatsuya Morita, MD, Takayuki Hisanaga, MD, Tatsuhiko Ishihara, MD, Tomoyuki Iwashita, MD, Keisuke Kaneishi, MD, PhD, Shohei Kawagoe, MD, Toshiyuki Kuriyama, MD, PhD, Takashi Maeda, MD, Ichiro Mori, MD, Nobuhisa Nakajima, MD, PhD, Tomohiro Nishi, MD, Hiroki Sakurai, MD, Satofumi Shimoyama, MD, PhD, Takuya Shinjo, MD, Hiroto Shirayama, MD, Takeshi Yamada, MD, PhD, Shigeki Ono, MD, Taketoshi Ozawa, MD, PhD, Ryo Yamamoto, MD, Satoru Tsuneto, MD, PhD 
Journal of Pain and Symptom Management 
Volume 49, Issue 5, Pages (May 2015)
DOI: /j.jpainsymman
Copyright © 2015 American Academy of Hospice and Palliative Medicine Terms and Conditions

2. Fig. 1
Survival curves of PiPS classification according to each clinical setting. Overall survival curves for high- (Group A: prognosis prediction in days, 0–13 days), intermediate- (Group B: weeks, 14–55 days), and low- (Group C: months/years, >55 days) risk groups defined in modified PiPS-A (a–c) and PiPS-B (d–f). PiPS=Prognosis Palliative Care Study.
Journal of Pain and Symptom Management  , DOI: ( /j.jpainsymman )
Copyright © 2015 American Academy of Hospice and Palliative Medicine Terms and Conditions